Skip to content

Exercise in Mental Illness Questionnaire: French Validation

Evaluation of the Knowledge, Attitudes and Behaviours of Health Professionals Regarding Physical Activity and Metabolic Health Screening for People With Mental Illness

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06329180
Enrollment
42
Registered
2024-03-25
Start date
2024-03-19
Completion date
2024-06-01
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise

Brief summary

The validation of the French version of the Exercise in Mental Illness Questionnaire - Health Practitioner Version (EMIQ-HP) is a prospective observational case-only study involving: (a) translation to French, (b) an expert consensus meeting with French speaking experts from Canada to reach a first version, (c) back translation to English, (d) evaluation of the back-translation by the original authors of the EMIQ-HP, (e) an expert consensus meeting with French speaking experts from Canada to reach a final version based on comments of the original authors, and (f) test-retest reliability study. Test-retest reliability will be analysed through two points of measurement with an interval of 7 days.

Detailed description

The aim of this study is to cross-culturally validate the French translation of the Exercise in Mental Illness Questionnaire - Health Practitioner version (EMIQ-HP) scale and investigate the test-retest reliability. We hypothesize that the French validated translation of the Exercise in Mental Illness Questionnaire - Health Practitioner version (EMIQ-HP) scale will show and excellent test - retest reliability. National and international experts from Belgium, Canada and Switzerland are requested to join the expert panel and requested to be available on 2 different occasions, i.e. following the first translation and following the feedback of the original authors on the back translation in order to reach consensus on the final version. For the test-retest part of this study, all health care providers of the Centre Hospitalier Psychiatrique Chêne aux Haies (i.e. nurses, psychologists, physiotherapists, somatic medical doctors, psychiatrists) will be invited to participate. Following written informed consent procedure, participants will complete the EMIQ-HP which will be completed a second time exactly one week following the first completion

Interventions

None listed

Sponsors

KU Leuven
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

National and international experts from Belgium and Canada will be requested to join the expert panel and requested to be available on 2 different occasions, i.e. following the first translation and following the feedback of the original authors on the back translation in order to reach consensus on the final version. For the test-retest part of this study, all health care providers of the Centre Hospitalier Psychiatrique Chêne aux Haies (i.e. nurses, psychologists, physiotherapists, somatic medical doctors, psychiatrists) will be invited to participate. There are no specific

Exclusion criteria

.

Design outcomes

Primary

MeasureTime frameDescription
Intra-class-correlation coefficients (ICC 3,17 days test -retestEMIQ items

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026